======= PPAPDC1A =======
== Gene Information ==
* **Official Symbol**: PLPP4
* **Official Name**: phospholipid phosphatase 4
* **Aliases and Previous Symbols**: N/A
* **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=196051|196051]]
* **UniProt**: [[https://www.uniprot.org/uniprot/Q5VZY2|Q5VZY2]]
* **Interactions**: [[https://thebiogrid.org/search.php?search=PPAPDC1A&organism=9606|BioGRID]]
* **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20PPAPDC1A|Open PubMed]]
* **OMIM**: N/A
== Function Summary ==
* **Entrez Summary**: N/A
* **UniProt Summary**: Displays magnesium-independent phosphatidate phosphatase activity in vitro. Catalyzes the conversion of phosphatidic acid to diacylglycerol. {ECO:0000269|PubMed:17590538}.
|PAP2|
|phosphatidate phosphatase activity|
|blastocyst hatching|
|hatching|
|organism emergence from protective structure|
|phospholipid dephosphorylation|
|phosphatase activity|
|blastocyst development|
|Fc-gamma receptor signaling pathway involved in phagocytosis|
|immune response-regulating cell surface receptor signaling pathway involved in phagocytosis|
|Fc receptor mediated stimulatory signaling pathway|
|Fc-gamma receptor signaling pathway|
|lipid modification|
|Fc receptor signaling pathway|
|dephosphorylation|
|phagocytosis|
|phospholipid metabolic process|
|in utero embryonic development|
|immune response-activating cell surface receptor signaling pathway|
|immune response-regulating cell surface receptor signaling pathway|
|immune response-activating signal transduction|
|immune response-regulating signaling pathway|
|activation of immune response|
|chordate embryonic development|
|embryo development ending in birth or egg hatching|
|positive regulation of immune response|
|organophosphate metabolic process|
|cellular lipid metabolic process|
|embryo development|
|identical protein binding|
|immune effector process|
|regulation of immune response|
|positive regulation of immune system process|
|lipid metabolic process|
|integral component of plasma membrane|
|regulation of immune system process|
|vesicle-mediated transport|
\\
=== CRISPR Data ===
^Screen^Score^
|[[:results:exp25|Oligomycin-A 2μM R00 exp25]]|-1.79|
|[[:results:exp485|GSK626616 14μM R08 exp485]]|-1.7|
^Gene^Correlation^
|[[:human genes:r:rrm1|RRM1]]|0.449|
Global Fraction of Cell Lines Where Essential: 0/739
^Tissue^Fraction Of Cell Lines Where Essential^
|1290807.0|0/1|
|909776.0|0/1|
|bile duct|0/28|
|blood|0/28|
|bone|0/26|
|breast|0/33|
|central nervous system|0/56|
|cervix|0/4|
|colorectal|0/17|
|esophagus|0/13|
|fibroblast|0/1|
|gastric|0/16|
|kidney|0/21|
|liver|0/20|
|lung|0/75|
|lymphocyte|0/16|
|ovary|0/26|
|pancreas|0/24|
|peripheral nervous system|0/16|
|plasma cell|0/15|
|prostate|0/1|
|skin|0/24|
|soft tissue|0/9|
|thyroid|0/2|
|upper aerodigestive|0/22|
|urinary tract|0/29|
|uterus|0/5|
== Essentiality in NALM6 ==
* **Essentiality Rank**: 4118
* **Expression level (log2 read counts)**: -7.68
{{:chemogenomics:nalm6 dist.png?nolink |}}